Clinical Trial Update: Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans

View source ↗

Summary

This ClinicalTrials.gov update reports on a study exploring intestinal metabolic reprogramming as a key mechanism of gastric bypass in humans, with relevance to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Pittsburgh | Conditions: Obesity, Diabetes Mellitus, Type 2 | Status: ACTIVE_NOT_RECRUITING